Market Cap : 7.22 B | Enterprise Value : 6.17 B | PE Ratio : | PB Ratio : 8.52 |
---|
NAS:IONS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IONS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Ionis Pharmaceuticals's change in receivables for the quarter that ended in Dec. 2020 was $-37.2 Mil. It means Ionis Pharmaceuticals's Accounts Receivable increased by $37.2 Mil from Sep. 2020 to Dec. 2020 .
Ionis Pharmaceuticals's change in receivables for the fiscal year that ended in Dec. 2020 was $-13.2 Mil. It means Ionis Pharmaceuticals's Accounts Receivable increased by $13.2 Mil from Dec. 2019 to Dec. 2020 .
Ionis Pharmaceuticals's Accounts Receivable for the quarter that ended in Dec. 2020 was $0.0 Mil.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Ionis Pharmaceuticals's Days Sales Outstanding for the three months ended in Dec. 2020 was 0.00.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Ionis Pharmaceuticals's liquidation value for the three months ended in Dec. 2020 was $356.9 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2020 was 34.429 (Mar. 2020 ) + 0.771 (Jun. 2020 ) + -11.143 (Sep. 2020 ) + -37.227 (Dec. 2020 ) = $-13.2 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Ionis Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2020 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 0 | / | 290.281 | * | 91 |
= | 0.00 |
2. In Ben Graham's calculation of liquidation value, Ionis Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:
Ionis Pharmaceuticals's liquidation value for the quarter that ended in Dec. 2020 is calculated as:
Liquidation Value | |||||||
= | Cash, Cash Equivalents, Marketable Securities | - | Total Liabilities | + | (0.75 * Accounts Receivable) | + | (0.5 * Total Inventories) |
= | 1892.375 | - | 1546.408 | + | 0.75 * 0 | + | 0.5 * 21.965 |
= | 356.9 |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline